Sanofi and GlaxoSmithKline said clinical trials of their COVID19 vaccine showed an insufficient immune response in older people, delaying its launch to late next year and marking a setback in the global fight against the pandemic.from Top Business News- News18.com https://ift.tt/3m6qOwr
